Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $9.5750, but opened at $10.20. Ambu A/S shares last traded at $10.20, with a volume of 597 shares.
Ambu A/S Price Performance
The company has a quick ratio of 1.67, a current ratio of 2.86 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $2.40 billion, a P/E ratio of 36.43 and a beta of 1.06. The business’s 50-day moving average is $10.49 and its two-hundred day moving average is $12.37.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $246.39 million during the quarter. Ambu A/S had a net margin of 7.81% and a return on equity of 8.13%.
About Ambu A/S
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Featured Articles
- Five stocks we like better than Ambu A/S
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
